Other
Derivative Liability
Boston Scientific Derivative Liability decreased by 6.0% to $1.23B in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2015
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase in liabilities may indicate unfavorable market movements against the firm's hedges or increased hedging activity.
Detailed definition
This represents the total fair value of all derivative contracts that are in a loss position for the company at the repo...
Peer comparison
Standard metric for any large financial institution or insurer with significant balance sheet hedging activities.
Metric ID:
other_derivative_liabilitiesHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.31B | $1.23B |
| QoQ Change | — | -6.0% |
Range$1.23B – $1.31B
Derivative Liability at Other Companies
Frequently Asked Questions
- What is Boston Scientific's derivative liability?
- Boston Scientific (BSX) reported derivative liability of $1.23B in Q1 2026.
- What does derivative liability mean?
- The total market value of all derivative contracts that currently have a negative value for the company.